Bullish
Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease
Telomir Pharmaceuticals announced the peer-reviewed publication of preclinical data showing that Telomir-Zn significantly improved survival and multip...